UM
WST icon

UniSuper Management’s West Pharmaceutical WST Stock Holding History

UniSuper Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51M Sell
6,995
-2,405
-26% -$735K 0.01% 395
2026
Q1 		$2.36M Buy
9,400
+91
+1% +$22.6K 0.02% 428
2025
Q4 		$2.56M Sell
9,309
-1,970
-17% -$539K 0.02% 417
2025
Q3 		$2.96M Buy
11,279
+1,293
+13% +$314K 0.02% 404
2025
Q2 		$2.18M Buy
9,986
+125
+1% +$26.7K 0.01% 457
2025
Q1 		$2.21M Buy
9,861
+1,702
+21% +$469K 0.02% 439
2024
Q4 		$2.67M Buy
8,159
+1,259
+18% +$396K 0.02% 370
2024
Q3 		$2.07M Sell
6,900
-15,022
-69% -$4.6M 0.02% 421
2024
Q2 		$7.22M Buy
21,922
+2,275
+12% +$804K 0.06% 172
2024
Q1 		$7.77M Buy
19,647
+2,762
+16% +$1.02M 0.07% 151
2023
Q4 		$5.95M Sell
16,885
-383
-2% -$136K 0.07% 171
2023
Q3 		$6.48M Sell
17,268
-143
-0.8% -$55.3K 0.08% 156
2023
Q2 		$6.66M Buy
+17,411
New +$6.22M 0.08% 160

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

UniSuper Management's WST Position: Q2 2026 in Review

UniSuper Management reduced its West Pharmaceutical (WST) stake by 26% in Q2 2026, selling an estimated $735K and leaving 6,995 shares worth $2.51M. The position accounts for 0.01% of the portfolio, ranked #395.

UniSuper Management first reported a position in WST in Q2 2023 and has held it in 13 quarters since. The position peaked at $7.77M in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • UniSuper Management held 6,995 shares of West Pharmaceutical worth $2.51M as of Q2 2026.
  • UniSuper Management sold 2,405 West Pharmaceutical shares in Q2 2026, an estimated $735K.
  • West Pharmaceutical made up 0.01% of UniSuper Management's portfolio in Q2 2026, its #395 holding.
  • UniSuper Management first reported a position in West Pharmaceutical in Q2 2023 and has held it in 13 quarters since.
  • UniSuper Management's West Pharmaceutical position peaked at $7.77M in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.